Which of the following tests are used to monitor antithrombotic therapy? I. International normalized ratio (INR) II. Activated partial thromboplastin time (APTT) III. Heparin assay
Rationale:
International normalized ratio (INR), activated partial thromboplastin time (APTT), and heparin assay are all used to monitor antithrombotic therapy. INR monitors warfarin therapy by assessing clotting time. APTT measures heparin effectiveness by evaluating intrinsic and common coagulation pathways. Heparin assays provide quantitative heparin levels, essential for adjusting doses accurately during treatment.
A: If I only is correct Limited to INR, this omits APTT and heparin assays, which are crucial for monitoring different antithrombotic agents, rendering it incomplete.
B: If III only is correct Restricting to heparin assay ignores INR and APTT’s roles in warfarin and heparin monitoring, respectively, missing comprehensive therapy assessment.
D: If II and III are correct Excluding INR neglects warfarin monitoring, a fundamental aspect of antithrombotic therapy, making this option insufficient for full therapeutic evaluation.
The safest drug to use to treat pregnant women who require anticoagulant therapy is:
Rationale:
Heparin is the safest drug to use to treat pregnant women who require anticoagulant therapy. Heparin does not cross the placenta, minimizing fetal risk, and has a well-established safety profile during pregnancy. It effectively prevents thrombosis without teratogenic effects, making it preferable. Other anticoagulants pose risks to fetal development or lack sufficient safety data in pregnancy.
A: Low-molecular-weight heparin offers advantages but carries some concerns about dosing and monitoring in pregnancy, making unfractionated heparin the more established safer choice.
B: Warfarin crosses the placenta and is teratogenic, causing fetal bleeding and congenital abnormalities, thus contraindicated in pregnancy.
C: Aspirin is not a primary anticoagulant for thrombosis treatment in pregnancy and presents bleeding risks without adequate anticoagulation efficacy.
Which of the following is not a good prognostic factor in patient with acute lymphoblastic leukemia?
Rationale:
Immunophenotype - mature B cell is not a good prognostic factor in patients with acute lymphoblastic leukemia. This immunophenotype often associates with more aggressive disease and poorer outcomes compared to other subtypes. Prognostic factors like gender, chromosomal number, and age have been linked to better responses and survival, whereas mature B cell lineage typically predicts a less favorable prognosis.
B: Gender - female generally indicates a better prognosis due to hormonal influences and treatment response differences, making it a favorable factor rather than a negative one.
C: Chromosomal number - hyperploidy correlates with improved prognosis by indicating a biologically less aggressive leukemia subtype, thus serving as a positive prognostic marker.
D: Age - 4 to 10 years old is considered optimal for prognosis, reflecting better tolerance to treatment and higher survival rates, contrasting with very young or older patients.
A 51-year-old male has been told by his PCP to take an aspirin a day. Why would this be recommended?
Rationale:
Aspirin has antiplatelet activity and prevents clots that cause strokes. Aspirin inhibits platelet aggregation by irreversibly blocking cyclooxygenase-1, reducing thromboxane A2 production, which decreases clot formation. This antithrombotic effect lowers the risk of ischemic strokes and heart attacks, making daily low-dose aspirin a common preventative measure for patients at risk of cardiovascular events.
A: He has arthritis and this will help with the inflammation and pain. This explanation neglects that low-dose aspirin is primarily for cardiovascular prevention, not significant anti-inflammatory effects, which require higher doses.
C: Aspirin acidifies the urine and he needs this for prostrate health. Aspirin does not alter urine pH nor is it used to manage prostate conditions, so this rationale is medically unfounded.
D: He has a history of gastrointestinal (GI) bleed, and one aspirin a day is a safe dosage. Aspirin often worsens GI bleeding risk, thus it’s usually contraindicated or used cautiously, not routinely recommended in such cases.
The mean cell volume of the patient is 90 fl and the reticulocyte production index is low. Which of the following is the most possible cause of anemia in this patient?
Rationale:
The most possible cause of anemia in this patient is aplastic anemia.
Aplastic anemia causes anemia due to bone marrow failure, resulting in low reticulocyte production despite a normal mean cell volume around 90 fl. This low reticulocyte production index reflects impaired erythropoiesis, distinguishing it from causes involving increased destruction or defective hemoglobin synthesis.
A: Thalassemia Typically presents with microcytic anemia and elevated reticulocyte counts due to ineffective erythropoiesis, contrasting with the normal MCV and low reticulocyte index here.
B: Vitamin B12 deficiency Usually causes macrocytic anemia with increased MCV, which contradicts the 90 fl mean cell volume in this case.
D: Sideroblastic anemia Generally exhibits microcytic or dimorphic anemia with increased or normal reticulocyte counts, inconsistent with the low reticulocyte production index observed.
The following drug reduces the effect of oral anticoagulants
Rationale:
Oral contraceptives reduce the effect of oral anticoagulants. Oral contraceptives contain estrogen, which increases the production of clotting factors and decreases the anticoagulant effect. This interaction leads to a diminished anticoagulant response, making oral contraceptives a significant factor in reducing the efficacy of oral anticoagulant therapy. Monitoring is essential when combined.
A: Broad spectrum antibiotic Broad spectrum antibiotics often disrupt gut flora, which can enhance oral anticoagulant effects by reducing vitamin K synthesis, leading to increased bleeding risk rather than reducing anticoagulant efficacy.
B: Cimetidine Cimetidine inhibits hepatic enzymes, potentially increasing the plasma concentration of oral anticoagulants, thereby enhancing rather than reducing their anticoagulant effect, which contradicts the question’s requirement.
C: Aspirin Aspirin acts synergistically with oral anticoagulants by inhibiting platelet function, increasing bleeding risk and enhancing anticoagulant effects, not diminishing or reducing their efficacy as the question demands.
Graft versus host disease is a complication of transfusion in patients of bone marrow transplantation. This can be best avoided by
Rationale:
Graft versus host disease can be best avoided by irradiating the blood components before transfusion.
Irradiation of blood components inactivates donor lymphocytes responsible for initiating graft versus host disease, preventing their proliferation and attack on the recipient’s tissues. This process is crucial for immunocompromised patients, such as those undergoing bone marrow transplantation, as it significantly reduces the risk of this often fatal complication.
A: Transfusion of packed cells does not eliminate viable T lymphocytes, leaving risk of graft versus host disease intact.
C: Transfusing fresh whole blood contains active lymphocytes that can trigger graft versus host disease, increasing patient vulnerability.
D: Replacement by crystalloids lacks cellular components and cannot provide necessary transfusion support or impact graft versus host disease risk.
Patient education when prescribing clopidogrel includes:
Rationale:
Patient education when prescribing clopidogrel includes advising patients not to take any herbal products without first discussing this with the provider. Clopidogrel interacts with various herbal supplements, which can increase bleeding risk or reduce drug efficacy. Ensuring patients communicate about herbal use prevents adverse effects and enhances safe medication management during antiplatelet therapy. This precaution supports optimal therapeutic outcomes.
B: Monitor urine output closely and contact the provider if it decreases. This instruction pertains primarily to renal function monitoring, which is not a standard requirement for clopidogrel therapy, as it does not typically affect kidney function directly.
C: Clopidogrel can be constipating; use a stool softener if needed. Constipation is not a recognized common side effect of clopidogrel, so recommending stool softeners is unnecessary and unrelated to this medication’s usual gastrointestinal profile.
D: The patient will need regular anticoagulant studies while on clopidogrel. Clopidogrel does not require routine coagulation monitoring like warfarin; its antiplatelet action is not measured by standard anticoagulant lab tests.
A nurse treating a patient receiving heparin should understand that hemorrhage can occur if medication administration leads to
Rationale:
Hemorrhage can occur if medication administration leads to high activated partial thromboplastin time.
High activated partial thromboplastin time (aPTT) indicates excessive anticoagulation caused by heparin, which prolongs clotting time and increases bleeding risk. Monitoring aPTT helps maintain therapeutic levels, preventing hemorrhage by avoiding over-anticoagulation during heparin therapy.
B: Low activated partial thromboplastin time suggests insufficient anticoagulation, reducing bleeding risk, thus it does not indicate hemorrhage risk during heparin treatment.
C: High prothrombin time reflects warfarin activity, not heparin’s effect, so it’s unrelated to hemorrhage caused by heparin administration.
D: Low prothrombin time implies faster clotting, which decreases bleeding potential and is not associated with heparin-induced hemorrhage.
What's the most appropriate test to diagnose haemophilia?
Rationale:
Partial Thromboplastin Time is the most appropriate test to diagnose haemophilia. This test assesses the intrinsic and common coagulation pathways, which are affected in haemophilia due to factor VIII or IX deficiencies. It measures clotting time, helping identify prolonged bleeding associated with haemophilia, unlike tests focusing on platelet function or the extrinsic pathway.
A: Prothrombin time evaluates the extrinsic coagulation pathway, not the intrinsic pathway affected in haemophilia, making it unsuitable for diagnosing this clotting disorder.
B: Bleeding time measures platelet function and blood vessel integrity, which are typically normal in haemophilia, thus it does not accurately reflect clotting factor deficiencies.
D: Platelet count quantifies platelet numbers but does not assess clotting factor activity or coagulation pathways, so it cannot detect haemophilia’s characteristic factor deficiencies.
A nurse treating a patient with beclomethasone prescription must understand that
Rationale:
Beclomethasone, a glucocorticoid, can cause suppression of adrenal gland function. Glucocorticoids like beclomethasone exert negative feedback on the hypothalamic-pituitary-adrenal axis, reducing endogenous cortisol production and potentially leading to adrenal insufficiency, especially with prolonged use or abrupt discontinuation, requiring careful monitoring to prevent complications.
B: b2 adrenergic agonists primarily affect bronchial smooth muscle relaxation and do not influence adrenal gland hormone production or suppression mechanisms.
C: a 1 adrenergic antagonists target vascular smooth muscle receptors and have no role in modulating adrenal gland function or corticosteroid feedback pathways.
D: Adrenal gland function is indeed affected by beclomethasone through feedback inhibition, so stating no effect contradicts established glucocorticoid pharmacodynamics.
Heparin is an anticoagulant produced by the basophils. The most likely mechanism heparin prevents blood clotting is by
Rationale:
Heparin prevents blood clotting by binding to antithrombin III to inactivate thrombin. This interaction enhances antithrombin III’s ability to inhibit thrombin and other proteases involved in coagulation, effectively halting the conversion of fibrinogen to fibrin, which is essential for clot formation, thus serving as a potent anticoagulant mechanism produced by basophils.
A: Inhibiting the formation of vitamin K dependent clotting factors relates to warfarin’s mechanism, not heparin’s, as heparin acts directly on thrombin via antithrombin III, not on vitamin K metabolism or synthesis.
B: Preventing the activation of platelets does not describe heparin’s function, as it mainly affects coagulation proteins rather than platelet activation pathways.
C: Preventing the aggregation of platelets refers to antiplatelet drugs like aspirin, not heparin, which targets thrombin inactivation to inhibit clot formation.
A nurse is treating a patient with acute manifestations of chronic obstructive pulmonary disease who's been prescribed levalbuterol. How is this medication classified and which of the following are its therapeutic uses?
Rationale:
Levalbuterol is classified as a Beta 2 adrenergic agonist and is used inhaled, short-acting for prevention of asthma episodes, including exercise-induced bronchospasm. This medication relaxes bronchial smooth muscle, providing rapid bronchodilation to ease acute airway obstruction, making it suitable for managing exacerbations of chronic obstructive pulmonary disease and asthma symptoms.
B: Alpha 1 adrenergic agonist; IV, long-acting treatment for bronchospasm and asthma This option misidentifies the receptor target and administration route, as levalbuterol targets Beta 2 receptors and is inhaled, not intravenous, with short-acting effects.
C: Benzodiazepine; Oral, short-acting, long-term control of asthma This choice confuses drug classes and purposes; benzodiazepines are CNS depressants, not bronchodilators, and do not treat asthma or COPD via oral administration.
D: All of the above This is inaccurate since only option A correctly classifies levalbuterol and its therapeutic use; the other choices misrepresent drug class, administration, and indication.
The nurse notes in the patient's medication order that the patient will be starting anticoagulant therapy. What is the primary goal of anticoagulant therapy?
Rationale:
Anticoagulant therapy primarily aims at preventing thrombus formation. This therapy works by inhibiting clotting factors in the blood, reducing the blood’s ability to form clots. It does not dissolve clots but helps stop new ones from developing or existing ones from growing larger, thereby decreasing the risk of conditions like stroke or pulmonary embolism in susceptible patients.
A: Dissolving an existing thrombus This option misrepresents anticoagulants’ function; they do not actively break down clots, which is the role of thrombolytic agents. Anticoagulants focus on clot prevention rather than clot resolution.
B: Stabilizing an existing thrombus Stabilization is not the goal; anticoagulants prevent further clot formation and expansion, rather than reinforcing or maintaining existing clots.
C: Dilating the vessel around a clot Anticoagulants do not affect blood vessel diameter; their function is biochemical inhibition of clotting factors, not mechanical vessel dilation or vasodilation.
The history and physical examination indicates that the patient may have taken too much warfarin. The nurse anticipates that the patient will receive which antidote?
Rationale:
Vitamin K is the antidote used to reverse the effects of warfarin overdose. Warfarin acts as an anticoagulant by inhibiting vitamin K-dependent clotting factors, so administering vitamin K restores these factors, helping to correct excessive bleeding risks. This intervention is critical for patients with elevated INR or bleeding due to excessive warfarin intake, ensuring safer coagulation levels.
B: Protamine Sulfate neutralizes heparin, not warfarin, by binding to it and reversing its anticoagulant effect. It has no direct impact on vitamin K pathways or warfarin-induced bleeding complications.
C: Potassium Chloride treats hypokalemia and is unrelated to anticoagulation reversal; it neither counteracts warfarin nor influences coagulation factors, making it irrelevant for warfarin toxicity.
D: Vitamin E is an antioxidant with no role in reversing warfarin effects. It does not interact with clotting factors or anticoagulant pathways involved in warfarin overdose management.
Low molecular weight heparins differ from conventional heparin in that
Rationale:
Low molecular weight heparins differ from conventional heparin in that all of the above statements are true.
They selectively inhibit factor Xa more than thrombin, cause less prolongation of clotting times like aPTT, and have slower metabolism, resulting in longer action duration. These combined features distinguish them pharmacodynamically and pharmacokinetically from conventional unfractionated heparin.
A: They selectively inhibit factor Xa but this alone does not capture all differences.
B: They do not significantly prolong clotting time, yet this is incomplete without the other properties.
C: They are metabolized slowly and have longer duration, but this alone is not comprehensive.
A patient has been instructed to take one enteric-coated low-dose aspirin a day as part of therapy to prevent strokes. The nurse will provide which instruction when providing patient teaching about this medication?
Rationale:
Take the medication with 6 to 8 ounces of water and with food. This guidance helps minimize gastrointestinal irritation commonly associated with aspirin use. Taking aspirin with food and adequate water reduces the risk of stomach discomfort and potential ulceration. Enteric-coated formulations further protect the stomach lining, but concurrent food intake remains essential for patient comfort and safety during low-dose aspirin therapy.
A: Low-dose aspirin therapy rarely causes problems with bleeding This statement overlooks aspirin’s known anticoagulant effects, which increase bleeding risk, especially gastrointestinal bleeding, making it an inaccurate reassurance. B: Aspirin needs to be taken on an empty stomach to ensure maximal absorption This advice conflicts with established recommendations to reduce gastric irritation by taking aspirin with food, not on an empty stomach. D: Coated tablets may be crushed if necessary for easier swallowing Crushing enteric-coated tablets destroys the protective layer, increasing gastric irritation and diminishing the intended delayed release effect, thus undermining safety and efficacy.
A nurse assigned to pulmonology must understand that medications used to treat manifestations of COPD include all of the following except
Rationale:
Benzodiazepines are not used to treat manifestations of COPD. Bronchodilators, methylxanthines, and anticholinergics help open airways and improve breathing, but benzodiazepines primarily act as sedatives and anxiolytics, which do not directly address COPD symptoms or airway obstruction.
B: Bronchodilators relax airway muscles, improving airflow and relieving COPD symptoms, making them essential in treatment protocols for this respiratory condition.
C: Methylxanthines stimulate the respiratory center and dilate bronchial airways, thus effectively managing COPD manifestations by enhancing breathing and reducing airway resistance.
D: Anticholinergics block parasympathetic nerve impulses, causing bronchodilation, which helps ease COPD symptoms by preventing bronchospasm and improving airflow in affected patients.
When writing a prescription for warfarin it is common to write on the prescription.
Rationale:
The brand name of warfarin and 'do not substitute' is commonly written on prescriptions for warfarin. This ensures consistency in medication effect, as warfarin has a narrow therapeutic index and different formulations may vary in bioavailability. Specifying the brand and prohibiting substitution reduces risks of adverse reactions or therapeutic failure associated with switching between generic and branded versions.
A: OK to substitute for generic suggests interchangeability, which is avoided for warfarin due to its narrow therapeutic margin and potential variability between brands, risking patient safety.
C: PRN refills implies as-needed use, which contradicts warfarin’s requirement for strict, regular dosing to maintain stable anticoagulation and prevent complications.
D: Refills for 1 year overlooks the necessity for frequent monitoring and dose adjustments in warfarin therapy, which precludes long-term automatic refills without clinical review.
A patient is receiving thrombolytic therapy, and the nurse monitors the patient for adverse effects. What is the most common undesirable effect of thrombolytic therapy?
Rationale:
The most common undesirable effect of thrombolytic therapy is internal and superficial bleeding. Thrombolytics dissolve clots by activating plasminogen to plasmin, which breaks down fibrin, leading to increased bleeding risk. This effect can manifest as bruising, bleeding at injection sites, or more severe hemorrhages. Monitoring bleeding signs is critical during therapy to ensure patient safety and timely intervention.
A: Dysrhythmias Dysrhythmias can occur but are less frequent and usually secondary to reperfusion rather than a direct effect of thrombolytic agents. They are not the primary concern during thrombolytic treatment.
B: Anaphylactic reactions Anaphylactic reactions are rare and not commonly associated with thrombolytic therapy. Such severe hypersensitivity responses are uncommon compared to bleeding complications.
D: Nausea and vomiting Nausea and vomiting may occur but are not as prevalent or life-threatening as bleeding. These gastrointestinal symptoms are minor adverse effects relative to hemorrhagic risks.
NADPH is a product of the hexose monophosphate pathway (HMP) in the red blood cell. The NADPH is used for the
Rationale:
NADPH is used for the reduction of glutathione.
NADPH generated by the hexose monophosphate pathway maintains glutathione in its reduced form, which is essential for protecting red blood cells from oxidative damage. Reduced glutathione neutralizes harmful reactive oxygen species, preventing cell membrane damage and hemolysis. This antioxidant function is critical for red blood cell survival under oxidative stress conditions.
A: Synthesis of fatty acids NADPH supports fatty acid synthesis primarily in tissues like the liver and adipose, not red blood cells, which lack the machinery for lipid biosynthesis.
C: Formation of ATP ATP synthesis occurs mainly through glycolysis and oxidative phosphorylation, processes distinct from the hexose monophosphate pathway and unrelated to NADPH production.
D: Removal of oxygen radicals NADPH indirectly aids in managing oxidative stress via glutathione, but it is not directly responsible for removing oxygen radicals itself.
Patients with pernicious anemia require treatment with:
Rationale:
Patients with pernicious anemia require treatment with Vitamin B12. Vitamin B12 deficiency causes pernicious anemia due to impaired absorption from intrinsic factor deficiency, necessitating supplementation to correct hematologic abnormalities and neurological symptoms. Iron supplementation, folic acid, or epogen alfa do not address the underlying vitamin B12 deficiency and therefore cannot reverse the disease process effectively.
A: Iron Iron supplementation treats iron-deficiency anemia but fails to correct vitamin B12 deficiency, which is the root cause of pernicious anemia, rendering it ineffective for this condition.
B: Folic acid Folic acid supplementation addresses folate deficiency anemia but does not resolve vitamin B12 absorption issues that cause pernicious anemia, thus it cannot treat this specific disorder.
C: Epogen alfa Epogen alfa stimulates red blood cell production but does not replace deficient vitamin B12, leaving the fundamental cause of pernicious anemia untreated and neurological complications unaddressed.
Route of heparin administration is
Rationale:
Heparin is administered via the subcutaneous route. Heparin cannot be given orally due to poor gastrointestinal absorption; subcutaneous injection allows for effective anticoagulation with controlled absorption. Intramuscular injection risks hematoma formation, while sublingual administration is not feasible given heparin's molecular size and solubility properties, making subcutaneous the preferred and safe method for delivery.
A: Oral Heparin is ineffective orally because it is degraded by digestive enzymes and poorly absorbed through the gastrointestinal tract, preventing it from achieving therapeutic anticoagulant levels systemically.
C: Intramuscular Intramuscular injection of heparin risks bleeding complications such as hematoma formation due to its anticoagulant effect, making this route unsafe and generally contraindicated.
D: Sublingual Heparin’s molecular structure and solubility do not allow adequate absorption through the mucous membranes under the tongue, rendering the sublingual route impractical and ineffective for anticoagulation.
nurse is administering epidural anesthesia to a patient with chronic lower back pain due to spinal cord compression by a posteriorly herniating intervertebral disk. To asses for any neurologic damage from hematoma formed during spinal or epidural anesthesia, a nurse must monitor which of the following signs/symptoms?
Rationale:
Sensation and movement of lower extremities must be monitored to assess for neurologic damage from hematoma during epidural anesthesia. This is crucial because spinal hematomas can compress nerve roots, leading to motor weakness or sensory loss in the lower limbs. Early detection through neurological assessment helps prevent permanent deficits and guides timely intervention to alleviate pressure and preserve function.
A: Indications of hematoma formation (redness, swelling) at insertion site do not reflect neurologic damage, as hematomas causing nerve compression occur internally and may not manifest externally.
C: Pupillary reflex evaluates cranial nerve function and brainstem integrity, unrelated to spinal cord compression or lower extremity neurologic status affected by epidural hematoma.
D: All of the above is inaccurate since only lower extremity sensation and movement directly indicate neurologic impairment from spinal hematoma, making this option overly inclusive.
A patient who is infected with hookworms produces signs and symptoms of anemia. Which of the following can be seen in the peripheral blood smear of the patient?
Rationale:
Basophilic stippling can be seen in the peripheral blood smear of a patient infected with hookworms who shows signs of anemia. This occurs due to impaired hemoglobin synthesis and accumulation of ribosomal RNA aggregates in red blood cells, which is characteristic of sideroblastic anemia or lead poisoning, conditions that share features with the anemia caused by hookworm infection.
A: Howell Jolly bodies represent nuclear remnants typically seen in patients with splenic dysfunction or after splenectomy, not commonly associated with hookworm-induced anemia or peripheral blood changes.
C: Target cells are red blood cells with a bullseye appearance usually found in liver disease, thalassemia, or hemoglobinopathies, unrelated to hookworm infections.
D: Spherocytes are spherical red blood cells typically found in hereditary spherocytosis or autoimmune hemolytic anemia, which differ from the peripheral smear changes seen in hookworm anemia.
A nurse is treating a patient diagnosed with nonallergic rhinitis who's been prescribed Phenylephrine to alleviate nasal congestion. What is the expected mechanism of action for this medication?
Rationale:
Phenylephrine agonizes alpha1-adrenergic receptors, causing reduction in the inflammation of the nasal membranes. Phenylephrine acts as a selective alpha1-adrenergic receptor agonist, leading to vasoconstriction in nasal blood vessels. This reduces blood flow and swelling in nasal mucosa, effectively relieving nasal congestion associated with nonallergic rhinitis without significant systemic effects or impact on other receptor types.
B: Phenylephrine does not antagonize beta2 adrenergic receptors; it primarily targets alpha1 receptors. Beta2 receptor antagonism would not cause bronchodilation but rather bronchoconstriction, which is unrelated to relieving nasal congestion in nonallergic rhinitis.
C: Phenylephrine does not agonize gamma2-cholinergic receptors or induce bronchoconstriction. Its mechanism involves alpha1-adrenergic receptor activation, not cholinergic pathways, making this option incompatible with its pharmacological profile.
D: Phenylephrine does not antagonize muscarinic receptors nor specifically reduce inflammation in lower respiratory passages. Its effect is localized vasoconstriction in nasal membranes, not muscarinic receptor-mediated anti-inflammatory action.
A patient who is suspected of having acute viral hemorrhagic fever reveals history of tick bite. Which of the following is the most possible causative agent?
Rationale:
Crimean Congo virus is the most likely causative agent of acute viral hemorrhagic fever following a tick bite. This virus is transmitted primarily by ticks, particularly Hyalomma species, and is endemic in regions where tick exposure is common, aligning with the patient's history and symptom presentation of hemorrhagic fever after a tick bite.
A: Hantavirus primarily transmits via rodent excreta, not ticks, making it an unlikely cause of hemorrhagic fever in this case. It presents differently and lacks direct vector association with ticks.
B: Rift Valley virus is mosquito-borne, mainly transmitted by Aedes species, and not linked to tick bites. Its epidemiology does not match the patient’s tick exposure history.
D: Marburg virus spreads through direct contact with infected bodily fluids, not ticks. It is associated with bat exposure and human-to-human transmission, differing from tick-borne viral hemorrhagic fevers.
A nurse who's well-versed in respiratory pharmacotherapy understands that contraindications/precautions for prescribing beta 2 adrenergic agonists to patients with documented history of tachycardia include
Rationale:
Beta 2 adrenergic agonists require caution in patients with diabetes, hyperthyroidism, hypertension, and angina due to their potential to exacerbate these conditions through increased heart rate and metabolic effects. These comorbidities elevate cardiovascular risks, making careful assessment and monitoring essential when prescribing beta 2 agonists to avoid adverse outcomes related to tachycardia and systemic stimulation.
A: Exercising caution in patients with post-traumatic stress disease does not relate directly to beta 2 agonist contraindications, as this condition involves psychological rather than cardiovascular or metabolic concerns.
C: Chronic ulcers are unrelated to beta 2 adrenergic agonist use, lacking direct effects on ulcer pathophysiology or drug-related exacerbation, thus not warranting special caution.
D: None of the above dismisses valid contraindications, ignoring well-established risks in patients with specific cardiovascular and metabolic disorders requiring careful use of beta 2 agonists.
The most definite beneficial results are obtained in the use of anticoagulants for the following purpose
Rationale:
The most definite beneficial results are obtained in the use of anticoagulants for the prevention of venous thrombosis and pulmonary embolism. Anticoagulants effectively inhibit clot formation in venous systems, significantly reducing the risk of deep vein thrombosis and life-threatening pulmonary embolism. Their efficacy in these conditions is well-established through extensive clinical trials, making this indication the most reliable and definitive for anticoagulant therapy.
A: Prevention of recurrences of myocardial infarction anticoagulants have limited benefit as antiplatelet agents are more effective for arterial thrombosis, making anticoagulants less definitive in this context.
C: Cerebrovascular accident anticoagulants are used selectively; their benefit is less certain and risk of hemorrhage complicates routine use for all stroke types.
D: Retinal artery thrombosis anticoagulants show minimal proven advantage; mechanical and inflammatory causes predominate, reducing the role of anticoagulation here.
When a patient has prescriptions for an inhaled beta 2 agonist and an inhaled glucocorticoid, a nurse should advise the patient
Rationale:
The patient should inhale the beta 2 agonist before inhaling the glucocorticoid. Inhaling the beta 2 agonist first opens the airways, enhancing the delivery and effectiveness of the glucocorticoid medication. This sequence maximizes drug absorption and optimizes therapeutic outcomes, ensuring better management of respiratory conditions by allowing the glucocorticoid to reach deeper lung tissues efficiently after airway dilation.
B: To inhale the beta 2 agonist after the glucocorticoid reduces medication efficiency because the airway remains constricted initially, limiting glucocorticoid penetration and diminishing its anti-inflammatory benefits.
C: Inhaling both simultaneously can cause improper dosing and suboptimal distribution, as the medications have different mechanisms requiring separate administration times to work effectively.
D: Suggesting the sequence doesn’t matter overlooks the pharmacological importance of airway dilation first, which is critical for the glucocorticoid’s optimal lung deposition and therapeutic impact.
Anticholinergic effects like dry mouth and constipation are commonly observed with all of the following drug classes except
Rationale:
Anticholinergic effects like dry mouth and constipation are commonly observed with all of the following drug classes except 2nd generation H1 antagonists.
2nd generation H1 antagonists have minimal central nervous system penetration and exhibit low affinity for muscarinic receptors, thereby greatly reducing anticholinergic side effects such as dry mouth and constipation compared to other antihistamines and related agents.
A: 1st generation H1 antagonists exhibit significant anticholinergic activity due to their affinity for muscarinic receptors, causing classic side effects like dry mouth and constipation.
C: Intranasal antihistamines can cause local anticholinergic effects, including dryness, because of direct mucosal receptor blockade, contributing to symptoms such as nasal dryness and constipation.
D: Gamma-3 muscarinic receptor agonists primarily stimulate muscarinic receptors and do not cause anticholinergic effects, thus they are unrelated to dry mouth or constipation symptoms.